Is the price fair?
What FMS's price assumes
Fresenius Medical Care AG did not earn a profit over the last twelve months, so it has no trailing P/E and the price is read against sales instead: 0.33× revenue.
0.33
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 0.48
Price / book · as of 2025-Q4
- EV / sales
- 0.79
EV / sales
Details›
- Price / book2025-Q4
- 0.48
- EV / EBIT2025-Q4
- 8.53
- EV / sales2025-Q4
- 0.79
- Market capitalisation
- $12.7B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Care Facilities
Ranks #26 of 28 by Smart Score